First approved treatment for moderate-to-sever Alzheimer's disease

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2003年 / 38卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：617 / 617
页数：1
相关论文
共 50 条
  • [1] Memantine approved to treat moderate to severe Alzheimer’s disease
    Karen Marder
    [J]. Current Neurology and Neuroscience Reports, 2004, 4 (5) : 349 - 350
  • [2] A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease
    Mukhopadhyay, Sanchari
    Banerjee, Debanjan
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2021, 83 (04) : 1537 - 1552
  • [3] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer’s disease treatment
    Jinwei Zhang
    [J]. Inflammation Research, 2023, 72 : 1873 - 1876
  • [4] Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer's disease treatment
    Zhang, Jinwei
    [J]. INFLAMMATION RESEARCH, 2023, 72 (09) : 1873 - 1876
  • [5] FIRST ORAL TREATMENT FOR CROHN'S DISEASE APPROVED
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2023, 123 (09) : 20 - 20
  • [6] Donepezil approved for treatment of Alzheimer disease
    Nightingale, SL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (01): : 10 - 10
  • [7] Masitinib for the treatment of mild to moderate Alzheimer's disease
    Folch, Jaume
    Petrov, Dmitry
    Ettcheto, Miren
    Pedros, Ignacio
    Abad, Sonia
    Beas-Zarate, Carlos
    Lazarowski, Alberto
    Marin, Miguel
    Olloquequi, Jordi
    Auladell, Carme
    Camins, Antoni
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 587 - 596
  • [8] Treatment slows moderate to severe Alzheimer's disease
    Tanne, JH
    [J]. BRITISH MEDICAL JOURNAL, 2003, 326 (7393): : 784 - 784
  • [9] Pharmacologic treatment of Alzheimer's disease: An update on approved, unapproved therapies
    Steinberg, M
    [J]. FORMULARY, 1999, 34 (01) : 32 - +
  • [10] First Donepezil Transdermal Patch Approved for Alzheimer Disease
    Larkin, Howard D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (17): : 1642 - 1642
12345